Financial statements Sciencepharma
Cash inflows of SCIENCEPHARMA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Net cash from operating expenses | 3 056 587,68 | -3 849 492,90 | 5 705 084,17 |
| Net cash flow from investing activities | 7 501,37 | -537 043,98 | -28 496,89 |
| Net cash flow from financial activities | -5 663 785,60 | -8 360 114,26 | -445 314,46 |
| Total net cash flow | -2 599 696,55 | -12 746 651,14 | 5 231 272,82 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.